One single bone marrow harvesting from donors under 3 years of age: assessing safety and efficacy of the procedure.


Journal

Bone marrow transplantation
ISSN: 1476-5365
Titre abrégé: Bone Marrow Transplant
Pays: England
ID NLM: 8702459

Informations de publication

Date de publication:
07 2019
Historique:
received: 21 05 2018
accepted: 12 11 2018
revised: 11 11 2018
pubmed: 7 12 2018
medline: 16 5 2020
entrez: 7 12 2018
Statut: ppublish

Résumé

To candidate children as bone marrow donors raises two main concerns: donor safety and adequate marrow cell dose. Data in the field are limited and guidelines for child donor care management are lacking. In this context, we herein report the experience collected in our center by comparing very-young donors (defined as age ≤ 3 years) with young donors (defined as age > 3 years) who donated bone marrow (BM) for patients affected by beta-globin disorders.

Identifiants

pubmed: 30518979
doi: 10.1038/s41409-018-0415-y
pii: 10.1038/s41409-018-0415-y
doi:

Types de publication

Letter

Langues

eng

Sous-ensembles de citation

IM

Pagination

1121-1123

Auteurs

Katia Paciaroni (K)

International Centre for Transplantation in Thalassaemia and Sickle Cell Anaemia, Mediterranean Institute of Haematology, Rome, Italy. k.paciaroni@gmail.com.

Cecilia Alfieri (C)

International Centre for Transplantation in Thalassaemia and Sickle Cell Anaemia, Mediterranean Institute of Haematology, Rome, Italy.

Antonella Isgrò (A)

International Centre for Transplantation in Thalassaemia and Sickle Cell Anaemia, Mediterranean Institute of Haematology, Rome, Italy.

Gioia De Angelis (G)

International Centre for Transplantation in Thalassaemia and Sickle Cell Anaemia, Mediterranean Institute of Haematology, Rome, Italy.

Michela Ribersani (M)

International Centre for Transplantation in Thalassaemia and Sickle Cell Anaemia, Mediterranean Institute of Haematology, Rome, Italy.

Marco Marziali (M)

International Centre for Transplantation in Thalassaemia and Sickle Cell Anaemia, Mediterranean Institute of Haematology, Rome, Italy.

Mario Dauri (M)

Unit of Anesthesiology and Intensive Care "Tor Vergata" University, Rome, Italy.

Pietro Sodani (P)

Unit of Internal Medicine, Santa Croce Hospital, Fano, Italy.

Javid Gaziev (J)

International Centre for Transplantation in Thalassaemia and Sickle Cell Anaemia, Mediterranean Institute of Haematology, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH